122 related articles for article (PubMed ID: 4125022)
1. Remission of melanoma with D.N.C.B. treatment.
Malek-Mansour S
Lancet; 1973 Sep; 2(7827):503-4. PubMed ID: 4125022
[No Abstract] [Full Text] [Related]
2. [Regression of melanoma metastases after immunological therapy].
Malek-Mansour S; Castermans-Elias S; Lapière CM
Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
[No Abstract] [Full Text] [Related]
3. Editorial: Treatment of malignant melanoma.
Lancet; 1974 Nov; 2(7889):1119-20. PubMed ID: 4139412
[No Abstract] [Full Text] [Related]
4. [DNCB immunotherapy for removal of melanoma skin metastases].
Wätzig V
Dermatol Monatsschr; 1977 Oct; 163(10):848-50. PubMed ID: 923876
[No Abstract] [Full Text] [Related]
5. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
Falkson G; Van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
[No Abstract] [Full Text] [Related]
6. Topical immunotherapy of basal cell carcinomas with dinitrochlorobenzene.
Levis WR; Kraemer KH; Klingler WG; Peck GL; Terry WD
Cancer Res; 1973 Nov; 33(11):3036-42. PubMed ID: 4748451
[No Abstract] [Full Text] [Related]
7. [Adjuvant DNCB immunotherapy in malignant melanoma].
Weidner F; Djawari D
Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
[TBL] [Abstract][Full Text] [Related]
8. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
Illig L; Paul E
Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma: a case report.
Arena PJ
J Ky Med Assoc; 1973 Feb; 71(2):84-6. PubMed ID: 4687467
[No Abstract] [Full Text] [Related]
10. [Treatment of malignant melanoma with dinitrochlorobenzene ointment].
Loth H; Ehring F
Hautarzt; 1978 Mar; 29(3):141-6. PubMed ID: 640834
[TBL] [Abstract][Full Text] [Related]
11. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
Hemrajani RH; Kim KB; Amos WR; Mann DE
Melanoma Res; 2007 Aug; 17(4):257-9. PubMed ID: 17625458
[No Abstract] [Full Text] [Related]
12. Targeted therapy for metastatic melanoma.
Amaravadi RK; Flaherty KT
Clin Adv Hematol Oncol; 2007 May; 5(5):386-94. PubMed ID: 17673894
[No Abstract] [Full Text] [Related]
13. Advances in the treatment of malignant melanoma.
Krementz ET; Creach O
Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120
[No Abstract] [Full Text] [Related]
14. Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanoma.
Sullivan RJ; Flaherty KT
Nat Rev Clin Oncol; 2015 Nov; 12(11):625-6. PubMed ID: 26416151
[No Abstract] [Full Text] [Related]
15. [Dinitrochlorobenzene. Therapeutic use].
Heid E; Grosshans E; Laplanche G; Caussade P
Ann Dermatol Venereol; 1984; 111(9):841-9. PubMed ID: 6393839
[No Abstract] [Full Text] [Related]
16. Immunosurgical approach to the treatment of malignant melanoma using 2,4-dinitrochlorobenzene (DNCB).
Lukács L; István M
Neoplasma; 1984; 31(4):437-45. PubMed ID: 6472514
[TBL] [Abstract][Full Text] [Related]
17. [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients].
Burg G; Braun-Falco O
Dtsch Med Wochenschr; 1977 Feb; 102(6):210-1. PubMed ID: 832608
[No Abstract] [Full Text] [Related]
18. Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy.
Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671754
[No Abstract] [Full Text] [Related]
19. An evaluation of the surgical management of melanoma of the brain.
Bremer AM; West CR; Didolkar MS
J Surg Oncol; 1978; 10(3):211-9. PubMed ID: 651370
[No Abstract] [Full Text] [Related]
20. [The non-surgical treatment alternatives in disseminated malignant melanoma].
Klepp O
Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1526-8. PubMed ID: 1179368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
